2nd Annual Highly Potent Active Pharmaceutical Ingredients conference
Submitted by:
Andrew Warmington
The global market for highly potent active pharmaceutical ingredients is currently on a growth fast
CPhI South East Asia to open Thailand event in 2019
Submitted by:
Andrew Warmington
From 2019, CPhI South East Asia – organised by UBM – has announced it will
DCAT: From the podium
Submitted by:
Andrew Warmington
With over 10,000 industry professional attendees, this year’s DCAT Week, held from 19-23 March in
Meanwhile, last year was the “best” for chemicals and biotechnology company Lonza, which last year
In one of the industry's speeder acquisitions, CordenPharma acquired a Pfizer site in Boulder Colorado
Some interesting things are happening. Small companies (outside the top 50) are accounting for more
Healthcare at the push of a button
Submitted by:
Andrew Warmington
Wearable technology, trackable medicine, embedded body scanners: are these technologies the future of the healthcare
Where do you predict digital technologies will be in 10 years?
Mesko: If
What excites you most about healthcare digital technology and how did you move into
Brenntag breaks ground on new distribution facility in UK
Submitted by:
Andrew Warmington
German-headquartered chemical distribution company Brenntag has started work on a new multi-million pound distribution facility
BASF and Sinopec JV expands production of NPG
Submitted by:
Andrew Warmington
BASF and Sinopec have entered into a joint venture to expand production capacity for neopentylglycol
Oil recovery: squeezing the last drop
Submitted by:
Andrew Warmington
In tertiary recovery, enhanced oil recovery (EOR) techniques are employed to alter the capillary forces
International investor influx in Southeast Asia
Submitted by:
Andrew Warmington
Geopolitical stability, gradually rising living standards and the introduction of universal healthcare systems is fuelling
Merck expands in Asia and proposes to acquire Australia’s Viralytics
Submitted by:
Andrew Warmington
Leading science and technology company Merck (known as MilliporeSigma in the US) has announced agreements in
Indena opens new HPAPI kilolab
Submitted by:
Andrew Warmington
Pharmaceuticals company Indena has opened a new kilolab in Milan, Italy, dedicated to HPAPIs (natural